BioSpace News Archive

The mounting cases of people suffering from respiratory disorders is the foremost factor driving the global respiratory diagnostics market.

Sanofi reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with its new next-generation COVID-19 booster vaccine candidate modelled on the Beta variant antigen and including GSK’s pandemic adjuvant.

The International Atomic Energy Agency describes the process of radiation protection or radiation shielding as the protection of humans from the negative impact they may receive when exposed to harmful values of ionizing radiation.

Wilmington, Delaware, United States: The global life science tools market is anticipated to witness moderate growth during the forecast period between 2021 and 2031.

According to Transparency Market Research’s latest report on the global telehealth market for the historical period 2017–2019 and forecast period 2021–2028, the global telehealth market is driven by increase in population, need to expand healthcare access, rise in cases of chronic diseases and conditions, shortage of physicians, advancements in telecommunications, government support, surge in awareness, and increase in technology adoption in the wake of COVID-19

Wilmington, Delaware, United States: Growing incidences of injuries as well as deaths because of the mistakes in the medical prescriptions are putting a constant pressure on the overall healthcare sector.

International medical imaging IT and cybersecurity company Sectra has signed a contract with Homerton Healthcare NHS Foundation Trust in the UK.

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors in immuno-oncology, announced that it is strengthening its scientific team with the appointement of Dr Xavier Leroy as CSO.

Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, announced that the Japan UPSC UENO Patent Office has issued a patent, No. 7075594, to Aruna Bio and the University of Georgia Research Foundation allowing broad claims on the composition of neural exosomes and their use as a therapeutic for neurological diseases and disorders.

Ainnocence, a global biotech startup on a mission to accelerate drug discovery using a fast, self-evolving AI drug design platform, launched at the 2022 BIO International Convention.